Korro Bio (KRRO) Tax Provisions (2020 - 2026)
Korro Bio's (KRRO) quarterly Tax Provisions came in at $95000.0 in Q1 2026, up 100.39% on a QoQ basis from -$24.5 million in Q4 2025.
Korro Bio (KRRO) Tax Provisions (2020 - 2026) Analysis & Trends
Korro Bio (KRRO) has 7 years of Tax Provisions data on file, last reported at $95000.0 in Q1 2026.
- Quarterly Tax Provisions changed N/A year-over-year to $95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.4 million (down 19773.39% YoY) and the FY2025 annual result came in at -$24.5 million, down 17468.79% from the prior year.
- Tax Provisions climbed to $95000.0 in Q1 2026, from -$24.5 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $103000.0 in Q4 2024 to a low of -$24.5 million in Q4 2025.
- A 5-year average of -$2.0 million and a median of $14500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 1250.0% — and 2025, when it slumped 23877.67%.
- Tracing KRRO's Tax Provisions over 5 years: stood at $19000.0 in 2022, then jumped by 42.11% to $27000.0 in 2023, then jumped by 281.48% to $103000.0 in 2024, then tumbled by 23877.67% to -$24.5 million in 2025, then jumped by 100.39% to $95000.0 in 2026.
- The last three Tax Provisions figures came in at $95000.0 (Q1 2026), -$24.5 million (Q4 2025), and $1000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | Korro Bio | 232.92 Mn | 117.88 Mn | - | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108,000.00 |
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | -24.49 Mn |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Dec 31, 2020 | -25,000.00 |
| Sep 30, 2020 | 15,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 38,000.00 |